Advertisement
Screener

KODIAK SCIENCES INC. (KOD) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

KODIAK SCIENCES INC. Cash Flow Breakdown

Cash flow breakdown shows where KODIAK SCIENCES INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $136.01M went out.
  • Fiscal year ended 2025-12-31: from investing, $506.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $178.30M came in.
  • Fiscal year ended 2025-12-31: change in cash, $41.79M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$136.01M-$506.00K$5.16M$173.14M*$41.79M
2024-12-31-$117.32M-$755.00K$394.00K-$117.57M
2023-12-31-$154.18M$249.23M$60.00K$95.07M
2022-12-31-$206.46M-$336.51M$1.77M-$541.08M
2021-12-31-$182.27M-$38.80M$7.74M-$212.89M
2020-12-31-$83.43M$104.83M-$487.00K$612.02M$105.85M*$738.78M
2019-12-31-$39.15M-$137.00M-$132.00K$297.62M$2.20M*$123.54M
2018-12-31-$29.03M-$581.00K$0.00$83.75M$32.72M*$86.86M
2017-12-31-$17.66M-$209.00K$0.00$3.00K$9.63M*-$8.23M
2016-12-31-$16.05M-$771.00K-$4.00K$5.00K-$16.94M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$46.24M*-$352.00K*$2.86M*
2026-03-31-$40.01M-$942.00K$922.00K-$40.33M
2025-12-31-$39.38M*-$43.00K*$4.19M*$173.06M*
2025-09-30-$32.88M*-$60.00K*$813.00K*
2025-06-30-$34.67M*-$133.00K*$38.00K*
2025-03-31-$29.08M-$270.00K$124.00K-$29.22M
2024-12-31-$30.07M*-$124.00K*$356.00K*
2024-09-30-$21.16M*-$205.00K*$0.00*
2024-06-30-$26.49M*-$260.00K*$0.00*
2024-03-31-$39.60M-$166.00K$38.00K-$39.73M
2023-12-31-$32.24M*-$27.80M*$0.00*
2023-09-30-$32.76M*-$226.00K*$0.00*
2023-06-30-$41.96M*$103.84M*$51.00K*
2023-03-31-$47.22M$173.41M$9.00K$126.18M
2022-12-31-$55.08M*$67.00M*$0.00*
2022-09-30-$53.09M*$58.73M*$90.00K*
2022-06-30-$55.14M*-$443.95M*$2.00K*
2022-03-31-$43.16M-$18.29M$1.68M-$59.78M
2021-12-31-$59.03M*-$10.86M*$0.00*$1.99M*
2021-09-30-$51.95M*-$31.70M*$0.00*$2.04M*
2021-06-30-$36.66M*-$5.45M*$2.23M*
2021-03-31-$34.63M$9.22M$1.48M-$23.93M
2020-12-31-$27.02M*$58.86M*-$281.00K*$4.56M*$612.01M*
2020-09-30-$24.57M*$56.39M*$0.00*$813.00K*
2020-06-30-$13.90M*$56.78M*$720.00K*
2020-03-31-$17.93M-$67.20M$159.00K$99.63M*$14.66M
2019-12-31-$11.29M*-$113.28M*$297.20M*$2.14M*
2019-09-30-$7.70M*-$523.00K*$300.00K*
2019-06-30-$12.95M*$680.00K*$31.00K*
2019-03-31-$7.21M-$23.87M$83.00K-$31.03M
2018-12-31-$8.34M*-$525.00K*$83.71M*$1.82M*
2018-09-30-$4.98M*-$18.00K*$49.00K*-$1.10M*
2018-06-30-$4.45M*-$38.00K*$0.00*-$686.00K*
2018-03-31-$11.26M$0.00$0.00$32.68M*$21.42M
2017-12-31-$4.90M*-$50.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Vericel Corp (VCEL)United States$2.011B93.97
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Immunocore Holdings plc (IMCR)$1.613B-90.43